Stock Market Today: Small-cap stock below ₹100 hits buyers’ circuit for the seventh straight session on Tuesday. The planned expansion drove investor interest in Aayush Wellness stock.
Aayush Wellness share price hits buyers circuit
Small-cap stock below ₹100, Aayush Wellness share price opened at ₹94.09 on the BSE on Tuesday. Aayush Wellness share price was up almost 2% compared to the previous day’s closing price of 92.25. The stock thereafter continued to trade at the same level as its opening price of ₹94.09, which is also the upper circuit or upper price band for Aayush Wellness’ share price. The small-cap stock below ₹100 was thus locked in the buyers’ circuit.
Aayush Wellness share price has been rising regularly and was locked in the upper circuit for the seventh straight session. The small-cap stock has risen more than 50% in the last one month.
Aayush Wellness recent developments
Aayush Wellness on April 26, 2025, announced expansion into the healthcare segment, with smart health kiosks and medical support center.
Multiple expansion plans are being undertaken by Aayush Wellness. The company is taking a significant step toward accessible and proactive healthcare, launched its first healthcare centre in Virar (Mumbai), Maharashtra. Inspired by the E-Sanjeevani National Telemedicine Service of the Ministry of Health and Family Welfare, Aayush Wellness has installed a health ATM that shall conduct a wide range of diagnostics tests, in 2-3 minutes, maintain digital health records, and also facilitate Telemedicine to address health deficiencies before they become critical.
The company plans to invest up to ₹25 crore in the first phase and shall review further investments based on business requirements. This expansion will increase the company’s physical presence across geographies all over India, improve the offline distribution network for our products and provide complete preventive healthcare solutions under one roof.
The company envisions a future where preventive healthcare becomes a cornerstone of everyday life, reducing dependency on reactive treatments.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before taking any investment decisions.
